Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 10 - 28 tags : Approval save search
Global Immunotherapy Drugs Markets 2021-2026 - Launch of NG Immunotherapies / COVID-19 as Growth Catalyst / Approval of Novel Immunotherapy Drugs / Surge in Adoption of Car T-Cell Therapies
Published: 2021-10-28 (Crawled : 18:00) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.0%
H: 2.63%
C: 1.28%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.83%
H: 1.2%
C: 0.32%
covid immunotherapy therapy drug growth approval t-cell car-t
Arrow Approves 2022 Stock Repurchase Program
Published: 2021-10-28 (Crawled : 17:00) - prnewswire.com
AROW 4 | $22.7 3.65% 3.52% 79K
|
Finance
|
| O: 0.56%
H: 1.08%
C: 0.03%
approval program
TFF Pharmaceuticals Receives Approval from Health Canada to Enter Human Clinical Trials for Inhaled Formulation of Niclosamide to Treat COVID-19
Published: 2021-10-28 (Crawled : 14:00) - globenewswire.com
TFFP | $3.35 6.86% 6.42% 3.7K
|
Health Technology
|
| O: 0.0%
H: 3.71%
C: -1.28%
covid clinical trials trials trial approval
UP Fintech Holding Limited’s Singapore Subsidiary Receives Approval Regarding CDP Depository Agent in Singapore
Published: 2021-10-28 (Crawled : 09:00) - globenewswire.com
TIGR | $3.14 -0.32% -0.32% 530K
|
Finance
|
| O: -19.66%
H: 6.05%
C: 3.23%
approval
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.